A Comparison of Two Dosing Regimens of ASA Following Total Hip and Knee Arthroplasties

ASA 81 mg is associated with significantly less GI distress and nausea compared with ASA 325 mg. GI bleeding was equally prevalent between the 2 dosing regimens, so patients need to be informed of this risk regardless of the ASA dose.